Forte Biosciences, Inc.
NASDAQ:FBRX
6.38 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 18.036 | 0.041 | 0.049 | 0.051 |
| Kosten van de omzet
| 0 | 0.009 | 0 | 0.036 | 0.054 | 0.011 | 0 | 0 | 0 | 0 |
| Brutowinst
| 0 | -0.009 | 0 | -0.036 | -0.054 | -0.011 | 18.036 | 0.041 | 0.049 | 0.051 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Onderzoek- en ontwikkelingskosten
| 20.714 | 21.862 | 5.594 | 13.853 | 10.004 | 2.684 | 50.455 | 29.113 | 27.218 | 19.172 |
| Algemene en administratieve kosten
| 15.409 | 10.624 | 8.302 | 7.633 | 4.221 | 1.38 | 0.266 | 8.557 | 4.522 | 3.833 |
| Verkoop- en marketingkosten
| 0 | -0.009 | 0 | 0 | 0 | 0 | 12.543 | -0.292 | -0.255 | -0.232 |
| Verkoop-, algemene en administratieve kosten
| 15.409 | 10.615 | 8.302 | 7.633 | 4.221 | 1.38 | 12.809 | 8.265 | 4.267 | 3.601 |
| Overige kosten
| 0.479 | 0 | 0.017 | -0.222 | -0.205 | -0.007 | 0 | 0 | -0.05 | 0 |
| Bedrijfskosten
| 36.602 | 32.477 | 13.896 | 21.486 | 14.225 | 4.064 | 63.264 | 37.378 | 31.485 | 22.773 |
| Bedrijfsresultaat
| -36.602 | -32.486 | -13.896 | -21.486 | 17.832 | -4.064 | -45.853 | -37.629 | -31.691 | -22.954 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | -2.542 | -917.78 | -646.755 | -450.078 |
| Totaal overige inkomsten en kosten netto
| 1.124 | 1.01 | 0.017 | -0.222 | -0.205 | -0.005 | -1.403 | -1.3 | -1.787 | -0.102 |
| Inkomen voor belasting
| -35.478 | -31.476 | -13.879 | -21.708 | -46.487 | -4.069 | -47.256 | -38.929 | -33.478 | -23.056 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | -2.62 | -949.488 | -683.224 | -452.078 |
| Belastingkosten
| 0 | 0 | -0.017 | -0.201 | 32.057 | -0.003 | 1.699 | -2.6 | -3.674 | -0.204 |
| Nettowinst
| -35.478 | -31.476 | -13.862 | -21.708 | -78.544 | -4.066 | -48.955 | -38.929 | -33.478 | -23.056 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | -2.714 | -949.488 | -683.224 | -452.078 |
| WPA (Winst Per Aandeel)
| -12.17 | -24.92 | -19.96 | -38.854 | -157.927 | -48.251 | -915.18 | -997.5 | -634.796 | -474.15 |
| Verwaterde WPA
| -12.17 | -24.92 | -19.96 | -38.854 | -157.927 | -48.251 | -915.18 | -997.5 | -634.796 | -474.15 |
| EBITDA
| -35.439 | -32.477 | -13.896 | -21.45 | -46.433 | -4.053 | -43.694 | -36.705 | -31.171 | -22.485 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | -2.423 | -895.244 | -636.143 | -440.882 |